Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations

Clicks: 427
ID: 7959
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #3 of 22 articles by views in case reports in hematology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
We present a case report of a patient with acute myeloid leukemia (AML) characterized by the simultaneous presence of nucleophosmin 1 (NPM1) mutation and the breakpoint cluster region-Abelson (BCR-ABL) fusion oncogene. Our findings emphasize the importance of routinely including BCR-ABL in the diagnostic workup of AML in order to offer to the patients the most appropriate risk category and treatment options.
Reference Key
benedetta2019acutecase Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mariotti, Benedetta;Meconi, Federico;Palmieri, Raffaele;De Bellis, Eleonora;Lavorgna, Serena;Ottone, Tiziana;Martini, Vincenza;Lo-Coco, Francesco;Cicconi, Laura;Mariotti, Benedetta;Meconi, Federico;Palmieri, Raffaele;De Bellis, Eleonora;Lavorgna, Serena;Ottone, Tiziana;Martini, Vincenza;Lo-Coco, Francesco;Cicconi, Laura;
Journal case reports in hematology
Year 2019
DOI
10.1155/2019/6707506
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.